Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fungal cell membrane and cell envelope are vital structures that provide physical protection and maintain the physiological homeostasis of fungal cells (Nature Reviews Microbiology, 2014). The plasma membrane is a lipid bilayer primarily composed of ergosterol, which regulates membrane fluidity and permeability, while the surrounding cell wall is a complex network of chitin, beta-glucans, and mannoproteins providing structural rigidity (Journal of Fungi, 2020). These structures are critical for fungal virulence and serve as the primary targets for major antifungal classes because components like ergosterol and beta-glucans are absent in human cells (StatPearls, 2023). Polyenes like amphotericin B disrupt the membrane by binding ergosterol, whereas azoles inhibit its synthesis, and echinocandins target the cell wall by blocking glucan production. Therapeutic targeting of these structures is essential for treating systemic and superficial mycoses, although challenges such as nephrotoxicity and emerging drug resistance persist (NIH, 2022).
Drugs targeting the fungal cell membrane and envelope act by disrupting structural components or inhibiting their biosynthesis. Polyenes (e.g., Amphotericin B) bind to ergosterol in the fungal membrane, creating pores that cause leakage of intracellular contents (StatPearls, 2023). Azoles and allylamines inhibit enzymes in the ergosterol biosynthetic pathway—specifically lanosterol 14-alpha-demethylase and squalene epoxidase—leading to ergosterol depletion and membrane dysfunction (NIH, 2022). Echinocandins inhibit (1,3)-beta-D-glucan synthase, preventing the synthesis of a key structural polysaccharide in the cell wall, which results in osmotic instability and cell lysis (Nature Reviews Microbiology, 2014).
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal cell membrane and cell envelope.